Protective Role of Glutathione in the Hippocampus after Brain Ischemia
Stroke is a major cause of death worldwide, leading to serious disability. Post-ischemic injury, especially in the cerebral ischemia-prone hippocampus, is a serious problem, as it contributes to vascular dementia. Many studies have shown that in the hippocampus, ischemia/reperfusion induces neuronal death through oxidative stress and neuronal zinc (Zn2+) dyshomeostasis. Glutathione (GSH) plays an important role in protecting neurons against oxidative stress as a major intracellular antioxidant. In addition, the thiol group of GSH can function as a principal Zn2+ chelator for the maintenance of Zn2+ homeostasis in neurons. These lines of evidence suggest that neuronal GSH levels could be a key factor in post-stroke neuronal survival. In neurons, excitatory amino acid carrier 1 (EAAC1) is involved in the influx of cysteine, and intracellular cysteine is the rate-limiting substrate for the synthesis of GSH. Recently, several studies have indicated that cysteine uptake through EAAC1 suppresses ischemia-induced neuronal death via the promotion of hippocampal GSH synthesis in ischemic animal models. In this article, we aimed to review and describe the role of GSH in hippocampal neuroprotection after ischemia/reperfusion, focusing on EAAC1.
Top-30
Journals
|
1
2
3
|
|
|
International Journal of Molecular Sciences
3 publications, 6.82%
|
|
|
Biomolecules
2 publications, 4.55%
|
|
|
Frontiers in Pharmacology
2 publications, 4.55%
|
|
|
Frontiers in Nutrition
2 publications, 4.55%
|
|
|
Metabolic Brain Disease
2 publications, 4.55%
|
|
|
Scientific Reports
2 publications, 4.55%
|
|
|
Neurochemistry International
2 publications, 4.55%
|
|
|
Drug Metabolism and Disposition
1 publication, 2.27%
|
|
|
Antioxidants
1 publication, 2.27%
|
|
|
Materials Today Bio
1 publication, 2.27%
|
|
|
Chemometrics and Intelligent Laboratory Systems
1 publication, 2.27%
|
|
|
Oxidative Medicine and Cellular Longevity
1 publication, 2.27%
|
|
|
Medicinal Chemistry Research
1 publication, 2.27%
|
|
|
Journal of Stroke and Cerebrovascular Diseases
1 publication, 2.27%
|
|
|
Talanta
1 publication, 2.27%
|
|
|
Molecular Neurobiology
1 publication, 2.27%
|
|
|
Medicina
1 publication, 2.27%
|
|
|
Journal of Applied Toxicology
1 publication, 2.27%
|
|
|
Journal of Medicinal Chemistry
1 publication, 2.27%
|
|
|
ACS Nano
1 publication, 2.27%
|
|
|
Journal of the American Heart Association
1 publication, 2.27%
|
|
|
Chemical Science
1 publication, 2.27%
|
|
|
Renal Failure
1 publication, 2.27%
|
|
|
Inorganic Chemistry
1 publication, 2.27%
|
|
|
Biomedicines
1 publication, 2.27%
|
|
|
Neurochemical Research
1 publication, 2.27%
|
|
|
Mendeleev Communications
1 publication, 2.27%
|
|
|
International Immunopharmacology
1 publication, 2.27%
|
|
|
Neuroscience and Behavioral Physiology
1 publication, 2.27%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
|
|
|
Springer Nature
10 publications, 22.73%
|
|
|
MDPI
8 publications, 18.18%
|
|
|
Elsevier
8 publications, 18.18%
|
|
|
Frontiers Media S.A.
4 publications, 9.09%
|
|
|
American Chemical Society (ACS)
4 publications, 9.09%
|
|
|
Wiley
2 publications, 4.55%
|
|
|
Taylor & Francis
2 publications, 4.55%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 2.27%
|
|
|
Hindawi Limited
1 publication, 2.27%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 2.27%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 2.27%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 2.27%
|
|
|
2
4
6
8
10
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.